Amniotic Fluid Biomarker Research for Prediction of Postnatal Renal Function in Fetus With a Bilateral Abnormal Renal Development: National, Multicenter, Prospective and Non-interventional Study.
Amniotic Fluid Biomarker Research for Prediction of Postnatal Renal Function in Fetus With a Bilateral Abnormal Renal Development: National, Multicenter, Prospective and Non-interventional Study.
The discovery of antenatal bilateral renal anomaly poses an essential question: can we predict postnatal renal function? Ultrasound is insufficiently precise to predict postnatal renal function evolution.
The objective of this study is to estimate the specificity and sensitivity of amniotic fluid biomarkers to predict postnatal renal function in fetuses with bilateral developmental nephropathies.
Both fetuses with bilateral renal anomalies and control (healthy) fetuses will be included.
For this study amniotic fluid will only be collected according to routine clinical practice and only excess amniotic fluid sample will be used for the study.
The potentially identified biomarkers will not change routine management of the pregnancies in the study.
INCLUSION CRITERIA:
All fetuses with a bilateral abnormal renal development (structure modification of the parenchyma with or without urinary tract abnormalities associated)
The following sonographic criteria are used:
EXCLUSION CRITERIA: